48 results on '"Abaci N"'
Search Results
2. The complex microbiome of caries-active and caries-free supragingival plaques in permanent dentition
- Author
-
Celik, ZC, primary, Cakiris, A, additional, Abaci, N, additional, Yaniikoglu, F, additional, Ilgin, C, additional, Ekmekci, SS, additional, Celik, H, additional, and Tagtekin, D, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Clinical characteristics and genetic screening of an extended family with MEN2A
- Author
-
Algün, E., Abaci, N., Kösem, M., Kotan, Ç., Köseoğlu, B., Boztepe, H., Šekeroğlu, R., Aslan, H., Topal, C., Ayakta, H., Uygan, I., Alagöl, F., Erginel-Ünaltuna, N., and Aksoy, H.
- Published
- 2002
- Full Text
- View/download PDF
4. ULTRA-DEEP PYROSEQUENCING OF WHOLE MITOCHONDRIAL DNA SEQUENCING: A REPORT OF LEBERʼS HEREDITARY OPTIC NEUROPATHY: L25
- Author
-
Gedikbasi, A, Azakli, H, Ozturk, S, Cakiris, A, Cefle, K, Abaci, N, Palanduz, S, Palanduz, A, Emrence, Z, Çakar, A, and Ustek, D
- Published
- 2010
5. The presence of erythropoietin receptor in parathyroid cells
- Author
-
Öztürk, M., Üstek, D., Akbaş, F., Kösem, M., Abaci, N., Alagöl, F., Öztürk, G., and Kotan, Ç.
- Published
- 2007
- Full Text
- View/download PDF
6. Elevación de SPINK2 en leucemia mieloide aguda
- Author
-
Gezer Sümbül, Emrence Zeliha, Elverdi Tuğrul, Ar Muhlis Cem, Salman Yaylaz Burcu, Paçal Ferda, Ünüvar Ayşegül, Sarıman Melda, Eşkazan Ahmet Emre, Karaman Serap, Salihoğlu Ayşe, Karakaş Zeynep, Abacı Neslihan, and Sırma-Ekmekci Sema
- Subjects
leucemia mieloide aguda ,inhibidores de la serina proteasa ,spink2 ,husi-ii ,aml ,Medical technology ,R855-855.5 - Abstract
La leucemia mieloide aguda (AML, por sus siglas en inglés) es una enfermedad muy heterogénea. Aunque se puede clasificar a los pacientes en grupos de riesgo según sus mutaciones genéticas, el pronóstico dentro de cada categoría varía sustancialmente. Es perentorio identificar nuevos marcadores moleculares de la AML. Recientemente, se ha descrito la elevación del inhibidor de la serina peptidasa Kazal tipo 2 (SPINK2) en la AML, habiendo sido relacionada con peores resultados clínicos en metaanálisis, así como en un número limitado de pacientes con AML.
- Published
- 2023
- Full Text
- View/download PDF
7. Upregulation of SPINK2 in acute myeloid leukemia
- Author
-
Gezer Sümbül, Emrence Zeliha, Elverdi Tuğrul, Ar Muhlis Cem, Salman Yaylaz Burcu, Paçal Ferda, Ünüvar Ayşegül, Sarıman Melda, Eşkazan Ahmet Emre, Karaman Serap, Salihoğlu Ayşe, Karakaş Zeynep, Abacı Neslihan, and Sırma-Ekmekci Sema
- Subjects
acute myeloid leukemia ,aml ,husi-ii ,serin protease inhibitors ,spink2 ,Medical technology ,R855-855.5 - Abstract
Acute myeloid leukemia (AML) is a highly heterogeneous disease. Although patients can be classified into risk groups based on their genetic changes, the prognosis of disease within these categories varies widely. This situation raises the need to search for new molecular markers related to AML. Serine peptidase inhibitor Kazal type 2 (SPINK2) has recently been reported to be upregulated in AML and associated with poor outcomes by meta-analysis and in a limited number of AML patients.
- Published
- 2023
- Full Text
- View/download PDF
8. SAT0597 New autoinflammatory phenotype manifesting as hypocomplementemic urticarial vasculitis and associated with homozygous agbl3 variant
- Author
-
Gül, A., primary, Abaci, N., additional, and Sirma Ekmekci, S., additional
- Published
- 2018
- Full Text
- View/download PDF
9. 14 Yıllık Huntington Hastalığı Genetik Tanı Sonuçlarının Değerlendirilmesi
- Author
-
KÖMÜRCÜ BAYRAK E., PODA M., GÜVEN Z. G., GEYİK F., ÇOBAN N., GÜLEÇ Ç., ABACI N., AKBAŞ F., ÖZBEK U., ÜNALTUNA N., and AKBAŞ, FAHRİ
- Published
- 2014
10. AB0003 XBP1 splicing and reduced XBP1 expression in behçet’s disease
- Author
-
Abaci, N., primary, Cosan, F., additional, Azakli, H., additional, Sirma-Ekmekci, S., additional, Emrence, Z., additional, Cakiris, A., additional, Ombrello, M.J., additional, Ustek, D., additional, and Gul, A., additional
- Published
- 2013
- Full Text
- View/download PDF
11. AB0060 The association of HLA-B*51 expression with endoplasmic reticulum stress
- Author
-
Cosan, F., primary, Emrence, Z., additional, Azakli, H., additional, Sirma, S., additional, Aktas-Cetin, E., additional, Abaci, N., additional, and Ustek, D., additional
- Published
- 2013
- Full Text
- View/download PDF
12. Whole genome sequencing, assembly and annotation of Halomonas smyrnensis, a levan producing halophilic bacterium
- Author
-
Sogutcu, E, primary, Emrence, Z, additional, Arikan, M, additional, Cakiris, A, additional, Abaci, N, additional, Toksoy Oner, E, additional, Ustek, D, additional, and Arga, KY, additional
- Published
- 2012
- Full Text
- View/download PDF
13. The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease
- Author
-
Ekmekçi, A., K.S. Özcan, B, Güngör, Abaci, N., Osmonov, D., Zencirci, A., Toprak, E., Dönmez, C., Üstek, D., Güleç, Ç., and Eren, M.
- Published
- 2013
- Full Text
- View/download PDF
14. The relationship between coronary artery ectasia and eNOS intron 4a/b gene polymorphisms
- Author
-
Ekmekçi, A., Özcan, K.S., Abaci, N., Güngör, B., Osmonov, D., Tosu, R., Toprak, E., Gülec, C., Üstek, D., Öz, D., and Eren, M.
- Published
- 2013
- Full Text
- View/download PDF
15. Hipertrofik kardiyomiyopatide BOP geni varyasyonlari
- Author
-
Çağrı Güleç, Nihan Erginel Ünaltuna, Neslihan Abaci, Fatih Bayrak, Gökhan Kahveci, Evrim Kömürcü Bayrak, Abaci, N., Güleç, C., Bayrak, F., Kömürcü-Bayrak, E., Kahveci, G., Erginel-Ünaltuna, N., and Yeditepe Üniversitesi
- Subjects
Clinical heterogeneity ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Chromosomes, Human, Pair 21 ,CD8 Antigens ,Muscle Proteins ,Single-nucleotide polymorphism ,Bioinformatics ,Mice ,Exon ,Modifying gene ,Reference Values ,Internal medicine ,Genetic variation ,Genotype ,medicine ,Animals ,Humans ,BOP ,Aged ,business.industry ,Haplotype ,Hypertrophic cardiomyopathy ,Genetic Variation ,Proteins ,RNA-Binding Proteins ,Electroencephalography ,Single-strand conformation polymorphism ,Cardiomyopathy, Hypertrophic ,Middle Aged ,medicine.disease ,Null allele ,Molecular biology ,DNA-Binding Proteins ,Cross-Sectional Studies ,QT dispersion ,Mutation ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Chickens ,Echocardiography, Transesophageal ,Transcription Factors - Abstract
Objective: The observation that Bop null allele mice show underdeveloped right ventricle and excessive development of left ventricle, suggests the possible relationship between human BOP gene and hypertrophic cardiomyopathy (HCMP). In our study, we investigated this possible relationship between BOP gene variations and QT dispersion, a noninvasive arrhythmic risk marker for HCMP. Methods: This cross-sectional study consisted of 50 patients clinically diagnosed with HCMP and 60 healthy subjects. Exonic regions of BOP gene were amplified by polymerase chain reaction and amplified exonic regions were analyzed by Single-Strand Conformation Polymorphisms (SSCP). The samples with different migration patterns were sequenced through an automated sequencing system. Continuous variables were compared by unpaired t-test for independent samples or Mann-Whitney U test. Genotype-disease relationship was tested by Chi-square test. Results: The nucleotide substitutions G275>A and C965>A in exon 2 and 7 were determined only in HCMP group. The G707>C, C710>T, T761>C, T1217>C SNPs in exon 6 and 9 are also found in the control group. Significant differences were found between two groups (p=0.002 and p
- Published
- 2010
16. Investigation of the miR-637 and miR-523-5p as candidate biomarkers in breast cancer.
- Author
-
Coskunpinar E, Tiryakioglu DZ, Abaci N, Tukenmez M, and Pence S
- Subjects
- Humans, Female, Biomarkers, Biomarkers, Tumor genetics, Gene Expression Profiling, Fibroadenoma diagnosis, Fibroadenoma genetics, Breast Neoplasms diagnosis, Breast Neoplasms genetics, Breast Neoplasms pathology, MicroRNAs metabolism, Carcinoma, Ductal
- Abstract
Objectives: The distinction of benign lesions from malign tumors is crucial for the diagnosis and treatment of breast cancers., Background: The aim of this study was to investigate the use of miRNAs as plasma biomarkers for the discrimination of malign and benign breast tumors., Methods: Whole blood samples obtained from 40 individuals in 3 groups designated as invasive ductal carcinoma group, fibroadenoma group and healthy controls were included in this study. The expression levels of 372 miRNAs were determined using RT-PCR. Results: The comparison of fibroadenoma group with healthy controls revealed an upregulation of thirty miRNAs and downregulation of twenty-nine miRNAs. The comparison of invasive ductal carcinoma (IDC) group with controls has shown that eight miRNAs were upregulated while eleven miRNAs were downregulated. When comparing IDC and fibroadenoma groups, 15 miRNAs were found to be upregulated, while 10 miRNAs were downregulated. Further analysis of these miRNAs aimed to determine their power in distinguishing IDCs from fibroadenomas. Among the miRNAs analyzed, seven miRNAs have shown sufficient discriminative power, of which three miRNAs, namely miR-637, miR-523-5p and miR-490-3p, have shown a significantly high discriminative power., Conclusions: Circulating miR-637 and miR-523-5p combination maybe used to discriminate between invasive ductal carcinomas and fibroadenomas. (Tab. 9, Fig. 4, Ref. 30).
- Published
- 2023
- Full Text
- View/download PDF
17. The modulatory action of C-Vx substance on the immune system in COVID-19.
- Author
-
Tahrali I, Akdeniz N, Yilmaz V, Kucuksezer UC, Oktelik FB, Ozdemir O, Cetin-Aktas E, Ogutmen Y, Ergen A, Abaci N, Tuzun E, Oncul O, and Deniz G
- Subjects
- Humans, Cytokines, Interferon-gamma metabolism, T-Lymphocytes, Killer Cells, Natural, COVID-19
- Abstract
The modulatory effect of C-Vx, a novel therapeutic agent, on the immune system of COVID-19 patients was investigated. The functions of T and NK cells of COVID-19 patients with different disease severity were evaluated by flow cytometry in response to C-Vx stimulation. The levels of pro- and anti-inflammatory cytokines were detected by multiplex assay in supernatants after cell culture with C-Vx. Bradykinin, IRF3, and IFN-α levels were also measured by ELISA in the presence or absence of C-Vx stimulation. As a result, increased CD107a expression was observed on NK cells in response to C-Vx addition. The proliferation of T cell subsets was increased by C-Vx, decreasing by disease severity. IL-4 and IL-10 levels were elevated while IFN-γ and IL-17 levels were reduced in T cells following C-Vx stimulation. However, the levels of pro-inflammatory IL-1β, IL-6, IL-8, IFN-γ and GM-CSF were significantly increased upon C-Vx stimulation. IFN-α levels tended to increase after incubation with C-Vx. These findings support an immunomodulatory action of C-Vx on the immune system of patients with a mild and moderate phase of COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
18. Phytochemical profiling, in vitro biological activity, docking studies, and cytotoxicity assessments of Rondeletia odorata Jacquin: An unexplored plant of the coffee family.
- Author
-
Khursheed A, Ahmad S, Saleem M, Khan KU, Khan J, Orhan IE, Abaci N, Imran M, Tauseef S, Uddin R, Yawer MA, Tousif MI, Ojha SC, and Khurshid U
- Abstract
Rondeletia odorata Jacquin is a flowering plant that belongs to the coffee family. As a rich source of polyphenols with significant antioxidant potential, R. odorata may have health benefits. Therefore, in the current work, ethanolic extract of aerial parts and its n-hexane, ethyl acetate, and n-butanol soluble fractions were analyzed for their antioxidant potential and various enzyme inhibition properties. The total phenolic and flavonoid contents of the crude ethanol extract (ROE) and its n-hexane (ROH), ethyl acetate (ROEA), and n-butanol (ROB) fractions were determined spectrophotometrically, while metabolic profiling was established through UHPLC-MS analysis, which revealed the presence of 58 phytochemicals. Total phenolic and flavonoid contents of ROE extract were measured as 51.92 mg GA.Eq./g of dry extract and 52.35 mg Qu.Eq./g of the dry extract, respectively. In the DPPH radical scavenging activity assay, ROE and ROEA showed the highest potential with values of 62.13 ± 0.62 and 76.31% ± 1.86%, respectively, comparable to quercetin (80.89% ± 0.54%). Similarly, in the FRAP assay, the same pattern of the activity was observed with ROE and ROEA, which displayed absorbance values of 1.32 ± 0.01 and 0.80 ± 0.02 at 700 nm, respectively, which are comparable (1.76 ± 0.02) with the reference compound quercetin, whereas the ROH showed maximum metal-chelating capacity (62.61% ± 1.01%) among all extracts and fractions. Antibacterial activity assay indicated that the ROEA fraction was the most active against Serratia marcescens , Stenotrophomonas maltophilia , Bacillus subtilis , Klebsiella pneumonia , and Staphylococcus aureus , while the rest of the fractions showed good to moderate activity. Enzyme inhibition assays showed that ROEA fraction exhibited the highest activity with IC
50 values of 2.78 ± 0.42 and 3.95 ± 0.13 mg/mL against urease and carbonic anhydrase (CA), respectively. Furthermore, the docking studies of some of the major compounds identified in the extract revealed a strong correlation with their inhibitory activity. All extracts and fractions were also tested for their thrombolytic activity, and the ROB fraction showed a notable potential. Antiviral assay led to remarkable outcomes. Thus, it can be inferred that aerial parts of R. odorata are potential sources of bioactive components with several significant pharmacological activities., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Khursheed, Ahmad, Saleem, Khan, Khan, Orhan, Abaci, Imran, Tauseef, Uddin, Yawer, Tousif, Ojha and Khurshid.)- Published
- 2022
- Full Text
- View/download PDF
19. Optimization of Conventional Extraction Parameters for Recovering Phenolic Compounds from Potato ( Solanum tuberosum L.) Peels and Their Application as an Antioxidant in Yogurt Formulation.
- Author
-
Brahmi F, Mateos-Aparicio I, Garcia-Alonso A, Abaci N, Saoudi S, Smail-Benazzouz L, Guemghar-Haddadi H, Madani K, and Boulekbache-Makhlouf L
- Abstract
The aim of this work was to optimize the conventional parameters for the extraction of phenolic compounds from potato ( Solanum tuberosum L.) peels (PP). A central composite design (CCD) was used to establish the impacts of ethanol concentration (%), extraction time (min), and liquid/solid ratio (mL/g). The optimal experimental conditions that maximized extraction were ethanol at a concentration of 80% ( v/v ) for a time of 150 min with a ratio of 1 g/30 mL. Under optimal conditions, the total phenolic content (TPC) and the total flavonoid content (TFC) were 204.41 ± 8.64 mg GAE/100 g DW and 21.47 ± 0.76 mg QE/100 g DW, respectively. The PP extract had a potent antioxidant capacity tested by phosphomolybdate and DPPH assays with IC
50 of 10.65 ± 0.21 and 179.75 ± 3.18 µg/mL, respectively. Furthermore, by fortifying yogurt with PP as a natural ingredient, an improvement ofits physical, nutritional, antioxidant, and sensorial qualities was attempted in this study. The yogurts formulated with PP revealed significantly higher ( p ≤ 0.05) TPC, TFC, and antioxidant capacity in comparison with the control sample. In addition, the sensory evaluation showed that the yogurts enriched with PP were preferred over the control yogurt. The results indicate that PP can be considered an interesting byproduct since it can improve the nutritional, bioactive, and sensorial profile of yogurt, highlighting that PP, due to its high phenol content, can substantially improve the antioxidant effect of the new formulated yogurt.- Published
- 2022
- Full Text
- View/download PDF
20. Chemical Composition, Antioxidant and Anti-Enzymatic Activity of Golden Root ( Rhodiola rosea L.) Commercial Samples.
- Author
-
Polumackanycz M, Konieczynski P, Orhan IE, Abaci N, and Viapiana A
- Abstract
The aim of the study was to compare the chemical composition of the water and hydromethanolic extracts of R. rosea commercial samples in relation to their biological activity. For this purpose, the HPLC method was used for the determination of eleven phenolic compounds and AAS/AES was used for determination of five essential elements. Moreover, the contents of total phenolic, total flavonoid, total phenolic acids, and L(+)-ascorbic acid were determined. The antioxidant activity was assessed by DPPH (2,2-diphenyl-1-picrylhydrazyl) and ABTS radical scavenging activity, ferric-reducing/antioxidant power (FRAP), and cupric-reducing antioxidant capacity (CUPRAC) assays, while the inhibitory activity against AChE and BChE enzymes was determined using Ellman's method. The results showed that the hydromethanolic extracts of R. rosea were richer in phenolic compounds and showed higher antioxidant and neurobiological activity than the water extracts. However, the water extracts gave higher contents of determined elements. Among the individual phenolic compounds gallic acid (2.33 mg/g DW) and sinapic acid (386.44 µg/g DW) had the highest concentrations in the hydromethanolic and water extracts, respectively. Moreover, the most extracts were observed to be more efficient on BChE. Moreover, the correlation analysis indicated a high positive relationship between chemical composition and biological activity in both extracts of R. rosea .
- Published
- 2022
- Full Text
- View/download PDF
21. Kombucha - An ancient fermented beverage with desired bioactivities: A narrowed review.
- Author
-
Abaci N, Senol Deniz FS, and Orhan IE
- Abstract
Kombucha, originated in China 2000 years ago, is a sour and sweet-tasted drink, prepared traditionally through fermentation of black tea. During the fermentation of kombucha, consisting of mainly acidic compounds, microorganisms, and a tiny amount of alcohol, a biofilm called SCOBY forms. The bacteria in kombucha has been generally identified as Acetobacteraceae. Kombucha is a noteworthy source of B complex vitamins, polyphenols, and organic acids (mainly acetic acid). Nowadays, kombucha is tended to be prepared with some other plant species, which, therefore, lead to variations in its composition. Pre-clinical studies conducted on kombucha revealed that it has desired bioactivities such as antimicrobial, antioxidant, hepatoprotective, anti-hypercholestorelomic, anticancer, anti-inflammatory, etc. Only a few clinical studies have been also reported. In the current review, we aimed to overhaul pre-clinical bioactivities reported on kombucha as well as its brief compositional chemistry. The literature data indicate that kombucha has valuable biological effects on human health., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
22. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
- Author
-
Coskun FR, Percin-Pacal F, Emrence Z, Ar MC, Abaci N, Unuvar A, Eskazan AE, Elverdi T, Salihoglu A, Seflekci Y, Karakas Z, Soysal T, and Sirma-Ekmekci S
- Subjects
- Aged, Child, Humans, Mutation, RNA, Messenger genetics, Repressor Proteins genetics, Transcription Factors, Leukemia, Myeloid, Acute genetics, Proto-Oncogene Proteins genetics
- Abstract
Background: Acute myeloid leukemia (AML) is an aggressive hematological malignancy caused by a variety of genetic abnormalities and epigenetic dysregulation. The incidence of AML is strongly related to age, with the highest incidence rates being in older adults. The loss of function mutations in BCOR and BCORL1 genes have been identified in AML. BCL6 corepressor (BCOR) and BCL6 corepressor like 1 (BCORL1) are important epigenetic regu-lators as a member of Polycomb repressive complex 1 (PRC1.1), involved in histone modification processes., Methods: We analyzed the BCOR and BCORL1 mRNA expression in 74 adult and 22 pediatric patients with AML by Real-Time quantitative PCR in this study., Results: Our results indicated that both BCOR and BCORL1 mRNA expressions decrease with age (p = 0.009 and p = 0.008, respectively) and there is a positive correlation between BCOR and BCORL1 mRNA expression (p < 0.001). BCOR and BCORL1 mRNA expressions were not significantly different in both adult and pediatric patients with AML compared to control (p > 0.05)., Conclusions: Our findings indicate that expression of BCOR and BCORL1 mRNA are down-regulated with age. The increase in AML incidence with age suggests that age-associated BCOR and BCORL1 down-regulation might potentially contribute to age-related epigenetic alterations and form a predisposing condition for the development of elderly AML.
- Published
- 2020
- Full Text
- View/download PDF
23. Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction.
- Author
-
Taskin E, Guven C, Tunc Kaya S, Sariman M, Emrence Z, Ekmekci SS, Abaci N, Sevgiler Y, and Akcakaya H
- Subjects
- Humans, Signal Transduction, Transfection, Doxorubicin adverse effects, HMGB1 Protein metabolism, MAP Kinase Signaling System genetics, Toll-Like Receptor 4 metabolism
- Abstract
Purpose: Adriamycin (ADR) is a commonly used anti-cancer drug. ADR has toxic effects on cardiomyocytes and leads to heart failure. However, the underlying mechanism(s) by which ADR causes heart failure is still not clarified exactly. The aim of present study is to investigate whether ADR-induced heart failure is mediated via HMGB1/TLR4 to initiate the apoptosis through MAPK/AMPK pathways., Methods: H9c2 cell line was used to create four groups as a control, HMGB1 inhibition, ADR, ADR+HMGB1 inhibition. Silencing HMGB1 was performed with specific small interfering RNA. ADR was used at 2 µM concentration for 36 and 48 hours. Protein and genes expressions, apoptosis was measured., Results: Although ADR decreased AMPK, pAMPK, ERK1/2, pERK1/2, p38, JNK protein expression, ADR+HMGB1 inhibition led to change those protein expressions. The effect of silencing of HMGB1 prevented apoptosis induced by ADR in the cells. HMGB1 caused changes a kind of posttranscriptional modification on the TLR4 receptor. This posttranscriptional modification of TLR4 receptor led to decreased AMPK protein level, but phosphorylated-AMPK. This alternation of AMPK protein caused enhancing of JNK protein, resulting from the decline of p38 and ERK protein levels. Eventually, JNK triggered apoptosis by a caspase-dependent pathway. The number of TUNEL positive and active caspase 8 cells at ADR was high, although HMGB1 silencing could decrease the cell numbers., Conclusions: Inhibition of HMGB1 might prevent the lose of the cardiac cell by inhibition of apoptotic pathway, therefore HMGB1 plays an essential role as amplifying on ADR toxicity on the heart by TLR4.
- Published
- 2020
24. Serum sirtuin 1 protein as a potential biomarker for type 2 diabetes: Increased expression of sirtuin 1 and the correlation with microRNAs.
- Author
-
Gok O, Karaali Z, Ergen A, Ekmekci SS, and Abaci N
- Abstract
Background: Type 2 diabetes (T2DM) is characterized by hyperglycemia and insulin deficiency. Sirtuin 1 (SIRT1), serving as a deacetylase, is critical in the regulation of glucose and lipid metabolism. Recently, a number of studies have been conducted to investigate the role of SIRT1 in the pathogenesis of T2DM. However, there are no sufficient data about the relationship between SIRT1 and T2DM. The aim of this study was to analyze the expressions of microRNAs (miRNAs) (miR-34a, miR-9, miR-132, and miR-181a) involved in SIRT1 regulation and SIRT1 protein in the serum of T2DM patients and controls., Materials and Methods: miRNA expressions were determined by real-time polymerase chain reaction, and enzyme-linked immunosorbent assay was used to measure the SIRT1 protein levels in 25 T2DM patients and 25 controls., Results: Fasting blood glucose and glycated hemoglobin levels were significantly higher in patients when compared with controls ( P < 0.001). There was no difference for miRNA expressions between the groups ( P > 0.05). SIRT1 protein level was significantly increased in patients as compared to controls ( P = 0.044). Moreover, SIRT1 was negatively correlated with miR-181a ( r = -0.558, P = 0.005) and miR-132 ( r = -0.435, P = 0.034) in patients., Conclusion: Obtained results indicate that serum SIRT1 may be a potentially new biomarker for T2DM and also miR-181a and miR-132 may be involved in the development of T2DM by targeting SIRT1. This is the first study reporting on the effects of SIRT1 and related miRNAs in Turkish T2DM patients., Competing Interests: There are no conflicts of interest.
- Published
- 2019
- Full Text
- View/download PDF
25. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease.
- Author
-
Cosan F, Oku B, Gedar Totuk OM, Abaci N, Ustek D, Diz Kucukkaya R, and Gul A
- Subjects
- Adult, Behcet Syndrome blood, Behcet Syndrome diagnosis, Case-Control Studies, Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Heterozygote, Humans, Male, Phenotype, Risk Factors, Thrombosis blood, Thrombosis diagnosis, Behcet Syndrome genetics, Blood Coagulation genetics, Membrane Glycoproteins genetics, Minisatellite Repeats, Polymorphism, Genetic, Thrombosis genetics
- Abstract
Objectives: Behçet's disease (BD) has been recognized as an unclassified type of vasculitis with an accompanying tendency to thrombosis. No disease-specific pathology has been demonstrated so far to explain the prothrombotic state, and this predisposition is considered to be associated with endothelial activation/dysfunction. P-selectin glycoprotein ligand-1 (PSGL-1) variable number of tandem repeat (VNTR) polymorphism has an impact on the protein length, and heterozygosity affect of the PSGL-1 to P-selectin interaction, which has been found to be associated with an increased risk of thrombosis in patients with antiphospholipid syndrome. We aimed to analyze the association of PSGL-1 gene polymorphism, in a group of BD patients with and without thrombosis., Methods: The study group consisted of 136 BD patients (112 male, 24 female) with thrombosis, 120 BD patients without thrombosis (54 male, 66 female) during at least 5 years disease course, and 190 healthy controls (103 male, 87 female) All patients fulfilled the International Study Group criteria for classification of BD. Genotyping for the PSGL-1 gene exon 2 VNTR polymorphism was carried out with the amplification of genomic DNA and running of the polymerase chain reaction product on agarose gel electrophoresis., Results: The frequency of heterozygous genotypes (AB+AC+BC) was greater in BD patients with thrombosis compared to BD patients without thrombosis (33.1% vs. 20.8%, P = 0.028, odds ratio = 1.85). However, the increased frequency of heterozygous genotypes in BD patients with thrombosis did not reach a statistically significant level compared to healthy controls (33.1% vs. 32.6%)., Conclusions: PSGL-1 VNTR polymorphism may have limited contribution to the thrombotic tendency in patients with BD., (© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
26. Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.
- Author
-
Ciftci S, Keskin F, Abaci N, Akyuz F, Cakiris A, Badur S, Kaymakoglu S, and Ustek D
- Subjects
- Adult, Epitopes, B-Lymphocyte immunology, Epitopes, T-Lymphocyte immunology, Female, Hepatitis B e Antigens immunology, Hepatitis B virus physiology, Hepatitis B, Chronic virology, High-Throughput Nucleotide Sequencing methods, Humans, Liver Cirrhosis immunology, Liver Cirrhosis virology, Male, Middle Aged, Young Adult, Hepatitis B virus genetics, Hepatitis B virus immunology, Hepatitis B, Chronic immunology, Mutation, Missense, Viral Core Proteins genetics
- Abstract
Background: The HBV core protein plays a major role in host immune response. Mutations occurring in the HBV core gene may cause alterations in the major epitopes being effective in the host immune response. Until now, the persistent effects of core gene mutations on HBV infections have not been fully understood. The aim of this study is to analyze the core gene mutations for epitopes in the T lymphocytes [T helper (Th) and cytotoxic (CTL)] and B cell and C terminal region in patients with chronic hepatitis using ultra-deep pyrosequencing (UDPS) method., Methods: Eleven patients with chronic hepatitis B infection were included in the study. Amplification of the core gene was performed by a conventional PCR method. Mutations in the epitopes for T lymphocytes (Th and CTL) and B cell and in the C terminal region of HBV core gene were screened by UDPS. These mutations were analyzed in HBeAg positive and negative patients., Results: The minimum percentages of amino acid substitutions were found with 0.9% in HBeAg positive patients and 1.2% in negative patients. The number of missense mutation was higher in patients with HBeAg positive than negative patients (p < 0.005). The number of amino acid substitutions in the region of aa49 - 69 in the Th epitopes was found to be the highest in both HBeAg positive and negative patients. The mutation frequency was higher in the C-terminal region of the core protein compared to the Th, CTL, and B cell regions and these were more common in subjects with high-grade fibrosis. Some types of mutations (V27I, R47H, Y132I, R174STOP, S181P, Q182K) were only detected in subjects with liver cirrhosis., Conclusions: Unlike literature, our results show that there is no significant increase in number of mutations in the core gene of the virus during the anti-HBe positive period. The role of low abundance variants and mutations in the immune system can be understood using methods such as UDPS in the near future.
- Published
- 2018
- Full Text
- View/download PDF
27. Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method.
- Author
-
Keskin F, Ciftci S, Akyuz F, Abaci N, Cakiris A, Akyuz U, Demir K, Besisik F, Ustek D, and Kaymakoglu S
- Subjects
- Aged, Amino Acid Sequence, Antiviral Agents, Female, Genotype, Humans, Liver Cirrhosis, Male, Middle Aged, Ribavirin, Viral Nonstructural Proteins, Hepacivirus genetics, Hepatitis C, Chronic virology, High-Throughput Nucleotide Sequencing, Mutation
- Abstract
Background: HCV (Hepatitis C Virus) is genetically more diverse than HBV and HIV (Human Immunodeficiency Virus) and exists as quasispecies within infected individuals. This is due to the lack of efficient proofreading of the viral RNA-dependent RNA polymerase. Consequently, quasispecies emerge depending on the mutation rate of the viral polymerase, which may display a high level of genetic variability in a population. In infected individuals, HCV replicates and circulates as quasispecies composed of a complex mixture of different but closely related genomes that undergoes continuous change due to competitive selection and cooperation between arising mutants. The aim of this study is to investigate mutations in the NS5A region as a whole, including ISDR, PKRBD, IRRDR, and V3 of HCV genotype 1b cirrhosis patients being naive and nonresponders, treated with IFN (interferon) + ribavirin (RBN) by using an ultra-deep pyrosequencing method (UDPS)., Methods: During the study, five patients (four females, and one male, mean age 59.8 ± 11 years) with HCV related cirrhosis were analyzed. Three patients received IFN + RBN for six months, but two patients did not receive any therapy. HCV-RNA concentrations in patients' sera were determined using a COBAS AMPLICOR HCV MONITOR Test, Version 2.0. Genotyping was performed by using a commercial reverse hybridization method, Line Probe Assay. The quasispecies for the NS5A region were investigated using UDPS., Results: All five patients were HCV genotype 1b (Mean Child-Pugh score 7.2 ± 1.9, 2 pts Child A, 2 pts Child B, and one pt Child C) but only one patient had hepatocellular carcinoma (HCC). A total of 19 different mutations were detected in each of the five patients (ranging from 3 to 6 mutations per patient). In all five patients, several mutations in the ISDR and PKR-BD regions were detected. On the other hand, mutations in the V3 and IRRDR regions were only detected in one patient., Conclusions: UDPS is a new sequencing technology and a very sensitive method in detection of quasispecies with low frequency NS5A region mutations. These mutations may affect the antiviral response and development of HCC. However, further studies in larger number of patients should be conducted to clarify this hypothesis.
- Published
- 2017
- Full Text
- View/download PDF
28. Mitochondrial mutations in patients with congenital heart defects by next generation sequencing technology.
- Author
-
Abaci N, Arıkan M, Tansel T, Sahin N, Cakiris A, Pacal F, Sırma Ekmekci S, Gök E, and Üstek D
- Subjects
- Cardiomyopathies congenital, Child, Preschool, Female, High-Throughput Nucleotide Sequencing methods, Humans, Infant, Infant, Newborn, Male, Polymerase Chain Reaction, RNA, Ribosomal genetics, RNA, Transfer genetics, Sequence Analysis, DNA methods, Turkey, Cardiomyopathies genetics, DNA, Mitochondrial genetics, Heart Defects, Congenital genetics, Mutation genetics
- Abstract
It has been shown that mitochondrial deoxyribo nucleic acid mutations may play an important role in the development of cardiomyopathy, and various types of cardiomyopathy can be attributed to disturbed mitochondrial oxidative energy metabolism. Several studies have described many mutations in mitochondrial genes encoding for subunits of respiratory chain complexes. Thus, recent studies confirm that pathologic mitochondrial deoxyribo nucleic acid mutations are a major reason of diseases and determining them by next-generation sequencing will improve our understanding of dysregulation of heart development. To analyse mitochondrial deoxyribo nucleic acid mutations, the entire mitochondrial deoxyribo nucleic acid was amplified in two overlapping polymerase chain reaction fragments from the cardiac tissue of the 22 patients with congenital heart disease, undergoing cardiac surgery. Mitochondrial deoxyribo nucleic acid was deep sequenced by next-generation sequencing. A total of 13 novel mitochondrial deoxyribo nucleic acid mutations were identified in nine patients. Of the patients, three have novel mutations together with reported cardiomyopathy mutations. In all, 65 mutations were found, and 13 of them were unreported. This study represents the most comprehensive mitochondrial deoxyribo nucleic acid mutational analysis in patients with congenital heart disease.
- Published
- 2015
- Full Text
- View/download PDF
29. Metagenomic analysis of the microbial community in kefir grains.
- Author
-
Nalbantoglu U, Cakar A, Dogan H, Abaci N, Ustek D, Sayood K, and Can H
- Subjects
- Animals, Cattle, Lactobacillaceae classification, Lactobacillaceae metabolism, Molecular Sequence Data, Phylogeny, Sequence Analysis, DNA, Cultured Milk Products microbiology, Lactobacillaceae genetics, Lactobacillaceae isolation & purification, Metagenomics
- Abstract
Kefir grains as a probiotic have been subject to microbial community identification using culture-dependent and independent methods that target specific strains in the community, or that are based on limited 16S rRNA analysis. We performed whole genome shotgun pyrosequencing using two Turkish Kefir grains. Sequencing generated 3,682,455 high quality reads for a total of ∼1.6 Gbp of data assembled into 6151 contigs with a total length of ∼24 Mbp. Species identification mapped 88.16% and 93.81% of the reads rendering 4 Mpb of assembly that did not show any homology to known bacterial sequences. Identified communities in the two grains showed high concordance where Lactobacillus was the most abundant genus with a mapped abundance of 99.42% and 99.79%. This genus was dominantly represented by three species Lactobacillus kefiranofaciens, Lactobacillus buchneri and Lactobacillus helveticus with a total mapped abundance of 97.63% and 98.74%. We compared and verified our findings with 16S pyrosequencing and model based 16S data analysis. Our results suggest that microbial community profiling using whole genome shotgun data is feasible, can identify novel species data, and has the potential to generate a more accurate and detailed assessment of the underlying bacterial community, especially for low abundance species., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
30. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method.
- Author
-
Ciftci S, Keskin F, Cakiris A, Akyuz F, Pinarbasi B, Abaci N, Dincer E, Badur S, Kaymakoglu S, and Ustek D
- Subjects
- Adolescent, Adult, Drug Resistance, Viral genetics, Female, Genes, Viral, High-Throughput Nucleotide Sequencing methods, Humans, Male, Molecular Typing methods, Mutation, Sequence Analysis, DNA methods, Young Adult, Antiviral Agents therapeutic use, Hepatitis B virus drug effects, Hepatitis B virus genetics, Hepatitis B, Chronic virology
- Abstract
The potential antiviral resistance mutations within hepatitis B virus (HBV) reverse transcriptase (RT) region for nucleos(t)ide analogues (NA) are not well known. Especially, the effect of pre-existing antiviral drug resistance mutations in untreated patients in comparison to the resistance developed after treatment is not still clear. Sixteen naive chronic hepatitis B patients were studied. None of the patients had received NA treatment prior to the serum samples being collected. Forty-two potential NA resistance (NAr) mutation sites were screened by ultra-deep pyrosequencing (UDPS). After therapy, mutations conferring treatment resistance were detected by LiPA. Serum samples taken before treatment showed no classic primary or compensatory/secondary drug resistance mutations. However, NAr mutations found in 6 isolates (37.5%) involved 7 positions including rtL91I, rtT128I, rtQ215P, rtF221Y, rtN238D, rtC256S, and rtI266G. Substitutions at 3 NAr mutation sites (rtT128I, rtN238D, and rtC256S) were detected in 3 unresponsive patients developing drug resistance after NA treatment. One patient with rtI266G mutation also developed drug resistance after lamivudine (LAM) therapy. However, the relationship between rtI266G mutation and NA drug resistance was not previously reported. These results suggest that association of potential mutations besides the primary and secondary/compensatory resistance mutations should be investigated. Investigation of NAr mutations before treatment may be important for the success of the treatment., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
31. Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis.
- Author
-
Gurses C, Azakli H, Alptekin A, Cakiris A, Abaci N, Arikan M, Kursun O, Gokyigit A, and Ustek D
- Subjects
- Adult, Amino Acid Substitution, Case-Control Studies, DNA Fingerprinting, Epilepsy, Temporal Lobe etiology, Female, Humans, Male, Mitochondrial Diseases complications, Mitochondrial Diseases genetics, Mutation, Missense, Polymorphism, Single Nucleotide, Sclerosis, Young Adult, DNA, Mitochondrial genetics, Electron Transport Complex I genetics, Epilepsy, Temporal Lobe genetics, Epilepsy, Temporal Lobe pathology, Hippocampus pathology, Mitochondrial Proteins genetics, Mitochondrial Proton-Translocating ATPases genetics, NADH Dehydrogenase genetics
- Abstract
Introduction: Mitochondria have an essential role in neuronal excitability and neuronal survival. In addition to energy production, mitochondria also play a crucial role in the maintenance of intracellular calcium homeostasis, generation of reactive oxygen species and mechanisms of cell death. There is a relative paucity of data about the role of mitochondria in epilepsy. Mitochondrial genome analysis is rarely carried out in the investigation of some diseases. In mesial temporal lobe epilepsies (MTLE) cases, genome analysis has never been used previously. The aim of this study is to show mitochondrial dysfunctions using genome analysis in patients with MTLE-hippocampal sclerosis (HS)., Methods: 44 patients with MTLE-HS and 86 matched healthy unrelated controls were included in this study. The patients were divided into four groups according to their clinical presentation as the following: Group 1 consists of patients with intractable epilepsy who refused operation; Group 2 of operated seizure free patients; Group 3 of operated patients with seizures; and Group 4 unoperated seizure free patients with or without antiepileptic drugs. Blood samples were used to isolate DNA. Parallel tagged sequencing was employed to allow pyrosequencing of 130 samples. Complete mtDNA is amplified in two overlapping fragments (11 and 9 kb). The PCR amplicons were pooled in equimolar ratios. Titanium kits were used to produce shotgun libraries according to the manufacturer's protocol., Results: The average coverage in total was 130 ± 30 and an average of 2365127 bases and 337 bp fragment length was received from all samples. The mean mtDNA heteroplasmy in patients was 26.35 ± 12.3 and in controls 25.03 ± 9.34. Three mutations had prominently high significance in patient samples. The most significantly associated variation was located in the MT-ATP-8 gene (8502 A>T, Asn46Ile) whereas the other two were in the MT-ND4 (11994 C>T, Thr412Ile) and MT-ND5 (13231 A>C, Lys299Gln) genes., Conclusions: We have observed that three mutations were significantly related to the presence of epilepsy. These mutations were found at the 8502, 11994, and 13,231 bp of mtDNA, which resulted in amino acid changes at the MT-ATP-8, MT-ND4 and MT-ND5 genes. Finding mutations can lead us to knowing more about the pathophysiology of the MTLE disease., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
32. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
- Author
-
Mese S, Arikan M, Cakiris A, Abaci N, Gumus E, Kursun O, Onel D, Ustek D, Kaymakoglu S, Badur S, Yenen OS, and Bozkaya E
- Subjects
- Adult, Female, Genotype, Hepatitis B virus enzymology, Hepatitis B virus genetics, Hepatitis B, Chronic drug therapy, Hepatitis B, Chronic virology, Humans, Lamivudine pharmacology, Male, Nucleosides pharmacology, Nucleotides pharmacology, Reverse Transcriptase Inhibitors chemistry, Sensitivity and Specificity, Sequence Analysis, DNA, Antiviral Agents pharmacology, Drug Resistance, Viral genetics, Hepatitis B virus drug effects, Molecular Diagnostic Techniques methods, Mutation, RNA-Directed DNA Polymerase genetics, Reverse Transcriptase Inhibitors pharmacology
- Abstract
Despite the effectiveness of nucleoside/nucleotide analogues in the treatment of chronic hepatitis B (CHB), their long-term administration is associated with the emergence of resistant hepatitis B virus (HBV) mutants. In this study, mutations resulting in antiviral resistance in HBV DNA samples isolated from 23 CHB patients (nine treatment naïve and 14 treated previously) were studied using a line probe assay (INNO-LiPA HBV DR; Innogenetics) and ultradeep pyrosequencing (UDPS) methods. Whilst the INNO-LiPA HBV DR showed no resistance mutations in HBV DNA samples from treatment-naive patients, mutations mediating lamivudine resistance were detected in three samples by UDPS. Among patients who were treated previously, 19 mutations were detected in eight samples using the INNO-LiPA HBV DR and 29 mutations were detected in 12 samples using UDPS. All mutations detected by the INNO-LiPA HBV DR were also detected by UDPS. There were no mutations that could be detected by INNO-LiPA HBV DR but not by UDPS. A total of ten mutations were detected by UDPS but not by INNO-LiPA HBV DR, and the mean frequency of these mutations was 14.7 %. It was concluded that, although INNO-LiPA HBV DR is a sensitive and practical method commonly used for the detection of resistance mutations in HBV infection, UDPS may significantly increase the detection rate of genotypic resistance in HBV at an early stage.
- Published
- 2013
- Full Text
- View/download PDF
33. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
- Author
-
Ekmekci A, Güngör B, Özcan KS, Abaci N, Ilhan E, Ekmekci SS, Kemaloğlu T, Osmonov D, Ustek D, and Eren M
- Subjects
- Blood Flow Velocity, Case-Control Studies, Chi-Square Distribution, Coronary Angiography, Coronary Vessels diagnostic imaging, Echocardiography, Doppler, Color, Female, Fractional Flow Reserve, Myocardial, Gene Frequency, Genetic Predisposition to Disease, Humans, Logistic Models, Male, Middle Aged, No-Reflow Phenomenon diagnosis, No-Reflow Phenomenon enzymology, No-Reflow Phenomenon physiopathology, Odds Ratio, Phenotype, Polymerase Chain Reaction, Prospective Studies, Risk Factors, Coronary Circulation genetics, Coronary Vessels physiopathology, Introns, Microcirculation genetics, Nitric Oxide Synthase Type III genetics, No-Reflow Phenomenon genetics, Polymorphism, Genetic
- Abstract
Objective: Slow coronary flow (SCF) is reported to be associated with increased risk of cardiovascular disease. We have used coronary flow reserve measurement by transthoracic Doppler echocardiography to determine coronary microvascular function in patients with SCF and to determine whether the intron 4a/b polymorphism of the eNOS gene influences coronary endothelial function., Methods: Overall, 96 patients with SCF and 79 controls were enrolled in the study. Coronary flow was quantified according to the thrombolysis in myocardial infarction (TIMI) frame count (TFC) on angiogram. Coronary diastolic peak flow velocities (DPFV) were measured with color Doppler flow mapping at baseline and after dipyridamole infusion. Coronary flow reserve was calculated as the ratio of hyperemic to baseline DPFV. The eNOS 4a/b polymorphism was detected by PCR. Patients with diabetes were excluded from the study., Results: The SCF group was comparable to the control group in terms of demographic and clinical characteristics, except for hemoglobin and HDL-cholesterol levels, TFC of the left anterior descending artery, the circumflex artery, and the right coronary artery; the mean TFC was higher in the SCF group. Hyperemic DPFV and the hyperemic/baseline DPFV ratio were significantly lower in the SCF group when compared with the control group. However, baseline DPFV were similar in both groups. The number of patients with eNOS4 a/a and eNOS4 a/b phenotypes was statistically higher in SCF groups. The frequency of allele 'a' of the eNOS4 gene was also statistically higher in the SCF group. When patients were grouped according to the presence or absence of allele 'a' of the eNOS4 gene, statistically significant differences were found in the TFC of the left anterior descending artery, the circumflex artery; mean TFC; baseline DPFV; and hyperemic/baseline DPFV. Univariate analysis in which eNOS4 b/b was used as the referent group showed that the presence of allele 'a' of the eNOS4 gene significantly predicted SCF (odds ratio: 2.79, 95% confidence interval: 1.32-5.89; P=0.007). In multivariate analysis using a model adjusted for variables with a P value lower than 0.10 in univariate analyses, the presence of allele 'a' of the eNOS4 gene was found to be an independent predictor of SCF (odds ratio: 3.22, 95% confidence interval: 1.28-8.82; P=0.013)., Conclusion: The presence of allele 'a' may be a risk factor for microvascular endothelial dysfunction and higher TFCs in SCF patients.
- Published
- 2013
- Full Text
- View/download PDF
34. The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still's disease.
- Author
-
Cosan F, Emrence Z, Erbag G, Azakli H, Yilmazer B, Yazici A, Ekmekci SS, Abaci N, Ustek D, and Cefle A
- Subjects
- Adult, Case-Control Studies, Chi-Square Distribution, Exons, Female, Gene Frequency, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Odds Ratio, Phenotype, Pyrin, Risk Factors, Still's Disease, Adult-Onset immunology, Turkey, Cytoskeletal Proteins genetics, Mutation, Receptors, Tumor Necrosis Factor, Type I genetics, Still's Disease, Adult-Onset genetics
- Abstract
Adult onset Still's disease (ASD) is a systemic inflammatory disorder of unknown etiology. ASD is characterized by fever with unknown etiology, rash, arthritis, and involvement of several organ systems. FMF and TRAPS are two important autoinflammatory diseases which characterized with recurrent inflammatory attacks. We aimed in this study to investigate the MEFV gene and TNFRSF1A gene variations in ASD. Twenty consecutive Turkish ASD patients (14 female and 6 male; mean age 38.45 ± 14; mean disease duration 3.3 ± 2.3; mean age of the disease onset 35.1 ± 14.4) and 103 healthy controls of Turkish origin were analyzed. All ASD patients were genotyped for the 4 MEFV mutations (M694V, E148Q, V726A, M680I) and TNFRSF1A gene exon 2-3 and exon 4-5 by using sequence analysis. The healthy controls are genotyped using PCR-RFLP method for intron 4 variation. The results of MEFV gene mutations screening show an increase in the MEFV mutation rate in ASD group, but it was not significantly different (p = 0.442, OR 1.64, 95 % CI 0.409-6.589). T-C polymorphism (rs1800692) was the only variation in the intron 4 of TNFRSF1A gene that we observed at the ASD patients. The frequency of TT genotype was 15 %, TC: 45 %, and CC: 40 % in ASD patients and the frequencies were 22, 41, and 37 % in healthy controls, respectively. When we analyzed the allele difference between both groups, there was no difference (p = 0.54, OR 1.24, 0.619-2.496-2.654). The variations in MEFV may have role in ASD pathogenesis. Our findings suggest that there is no significant association between ASD and TNFRSF1A variations.
- Published
- 2013
- Full Text
- View/download PDF
35. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease.
- Author
-
Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Ugurlu S, Erer B, Abaci N, Ustek D, Meguro A, Ueda A, Takeno M, Inoko H, Ombrello MJ, Satorius CL, Maskeri B, Mullikin JC, Sun HW, Gutierrez-Cruz G, Kim Y, Wilson AF, Kastner DL, Gül A, and Remmers EF
- Subjects
- Case-Control Studies, DNA Fragmentation, Familial Mediterranean Fever metabolism, Gene Library, Genetic Predisposition to Disease, Genetic Variation, Genome-Wide Association Study, Genotype, High-Throughput Nucleotide Sequencing, Humans, Japan, Polymerase Chain Reaction, Pyrin, Sequence Analysis, DNA, Turkey, Behcet Syndrome genetics, Cytoskeletal Proteins genetics, Familial Mediterranean Fever genetics, Toll-Like Receptor 4 genetics
- Abstract
Genome-wide association studies (GWAS) are a powerful means of identifying genes with disease-associated common variants, but they are not well-suited to detecting genes with disease-associated rare and low-frequency variants. In the current study of Behçet disease (BD), nonsynonymous variants (NSVs) identified by deep exonic resequencing of 10 genes found by GWAS (IL10, IL23R, CCR1, STAT4, KLRK1, KLRC1, KLRC2, KLRC3, KLRC4, and ERAP1) and 11 genes selected for their role in innate immunity (IL1B, IL1R1, IL1RN, NLRP3, MEFV, TNFRSF1A, PSTPIP1, CASP1, PYCARD, NOD2, and TLR4) were evaluated for BD association. A differential distribution of the rare and low-frequency NSVs of a gene in 2,461 BD cases compared with 2,458 controls indicated their collective association with disease. By stringent criteria requiring at least a single burden test with study-wide significance and a corroborating test with at least nominal significance, rare and low-frequency NSVs in one GWAS-identified gene, IL23R (P = 6.9 × 10(-5)), and one gene involved in innate immunity, TLR4 (P = 8.0 × 10(-4)), were associated with BD. In addition, damaging or rare damaging NOD2 variants were nominally significant across all three burden tests applied (P = 0.0063-0.045). Furthermore, carriage of the familial Mediterranean fever gene (MEFV) mutation Met694Val, which is known to cause recessively inherited familial Mediterranean fever, conferred BD risk in the Turkish population (OR, 2.65; P = 1.8 × 10(-12)). The disease-associated NSVs in MEFV and TLR4 implicate innate immune and bacterial sensing mechanisms in BD pathogenesis.
- Published
- 2013
- Full Text
- View/download PDF
36. Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.
- Author
-
Gezer U, Ustek D, Yörüker EE, Cakiris A, Abaci N, Leszinski G, Dalay N, and Holdenrieder S
- Subjects
- Biomarkers, Tumor genetics, Chromatin Immunoprecipitation, DNA Methylation, Female, High-Throughput Nucleotide Sequencing, Humans, Interspersed Repetitive Sequences, Middle Aged, Colorectal Neoplasms blood, Colorectal Neoplasms genetics, DNA blood, Histones blood, Histones genetics, Histones metabolism, Nucleosomes genetics
- Abstract
Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N = 15) and healthy subjects (N = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p < 0.01; in H4K20me3: 54 vs. 88; p < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.
- Published
- 2013
- Full Text
- View/download PDF
37. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.
- Author
-
Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, and Kastner DL
- Subjects
- Analysis of Variance, Genome-Wide Association Study, Genotype, Humans, Japan, Minor Histocompatibility Antigens, NK Cell Lectin-Like Receptor Subfamily C genetics, Polymorphism, Single Nucleotide genetics, Receptors, CCR1 genetics, STAT4 Transcription Factor genetics, Statistics, Nonparametric, Turkey, Aminopeptidases genetics, Behcet Syndrome genetics, Epistasis, Genetic genetics, Gene Expression Regulation genetics, Genetic Predisposition to Disease genetics, HLA-B51 Antigen genetics
- Abstract
Individuals with Behçet's disease suffer from episodic inflammation often affecting the orogenital mucosa, skin and eyes. To discover new susceptibility loci for Behçet's disease, we performed a genome-wide association study (GWAS) of 779,465 SNPs with imputed genotypes in 1,209 Turkish individuals with Behçet's disease and 1,278 controls. We identified new associations at CCR1, STAT4 and KLRC4. Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln alterations, recessively conferred disease risk. These findings were replicated in 1,468 independent Turkish and/or 1,352 Japanese samples (combined meta-analysis P < 2 × 10(-9)). We also found evidence for interaction between HLA-B*51 and ERAP1 (P = 9 × 10(-4)). The CCR1 and STAT4 variants were associated with gene expression differences. Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I-ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behçet's disease.
- Published
- 2013
- Full Text
- View/download PDF
38. A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology.
- Author
-
Ustek D, Sirma S, Gumus E, Arikan M, Cakiris A, Abaci N, Mathew J, Emrence Z, Azakli H, Cosan F, Cakar A, Parlak M, and Kursun O
- Subjects
- Cell Separation, Chromosomes, Human virology, Flow Cytometry, Genes, Neoplasm, HEK293 Cells, High-Throughput Nucleotide Sequencing, Humans, Lentivirus genetics, Mutagenesis, Insertional, Sequence Analysis, DNA, Transfection, Genome, Human, Lentivirus physiology, Virus Integration
- Abstract
One application of next-generation sequencing (NGS) is the targeted resequencing of interested genes which has not been used in viral integration site analysis of gene therapy applications. Here, we combined targeted sequence capture array and next generation sequencing to address the whole genome profiling of viral integration sites. Human 293T and K562 cells were transduced with a HIV-1 derived vector. A custom made DNA probe sets targeted pLVTHM vector used to capture lentiviral vector/human genome junctions. The captured DNA was sequenced using GS FLX platform. Seven thousand four hundred and eighty four human genome sequences flanking the long terminal repeats (LTR) of pLVTHM fragment sequences matched with an identity of at least 98% and minimum 50 bp criteria in both cells. In total, 203 unique integration sites were identified. The integrations in both cell lines were totally distant from the CpG islands and from the transcription start sites and preferentially located in introns. A comparison between the two cell lines showed that the lentiviral-transduced DNA does not have the same preferred regions in the two different cell lines., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
39. Draft genome sequence of Halomonas smyrnensis AAD6T.
- Author
-
Sogutcu E, Emrence Z, Arikan M, Cakiris A, Abaci N, Öner ET, Ustek D, and Arga KY
- Subjects
- Fructans metabolism, Halomonas isolation & purification, Halomonas physiology, Molecular Sequence Data, DNA, Bacterial chemistry, DNA, Bacterial genetics, Genome, Bacterial, Halomonas genetics, Sequence Analysis, DNA
- Abstract
Halomonas smyrnensis AAD6(T) is a Gram-negative, aerobic, exopolysaccharide-producing, and moderately halophilic bacterium that produces levan, a fructose homopolymer with many potential uses in various industries. We report the draft genome sequence of H. smyrnensis AAD6(T), which will accelerate research on the rational design and optimization of microbial levan production.
- Published
- 2012
- Full Text
- View/download PDF
40. SET oncogene is upregulated in pediatric acute lymphoblastic leukemia.
- Author
-
Sirma Ekmekci S, G Ekmekci C, Kandilci A, Gulec C, Akbiyik M, Emrence Z, Abaci N, Karakas Z, Agaoglu L, Unuvar A, Anak S, Devecioglu O, Ustek D, Grosveld G, and Ozbek U
- Subjects
- Adolescent, Biomarkers, Tumor genetics, Child, Child, Preschool, DNA-Binding Proteins, Disease-Free Survival, Female, Histone Chaperones genetics, Humans, Kaplan-Meier Estimate, Male, Neoplasm Proteins metabolism, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factors genetics, Biomarkers, Tumor metabolism, Gene Expression Regulation, Neoplastic, Histone Chaperones metabolism, Precursor Cell Lymphoblastic Leukemia-Lymphoma metabolism, Transcription Factors metabolism, Up-Regulation
- Abstract
Aims and Background: The SET gene is a target of chromosomal translocations in acute leukemia and encodes a widely expressed multifunctional phosphoprotein. It has been shown that SET is upregulated in BCR-ABL1-positive cell lines, patient-derived chronic myeloid leukemia CD34-positive cells, and some solid tumors., Methods and Study Design: We determined the expression level of SET in 59 pediatric acute lymphoblastic leukemia patients who were BCR-ABL-negative using quantitative real-time reverse-transcriptase-polymerase chain reaction. Results. We showed that SET expression was significantly upregulated in 96.5% of B-acute lymphoblastic leukemia (28 of 29; 16.6 fold) and 93% of T-acute lymphoblastic leukemia (28 of 30; 47.6 fold) patients. This upregulation was not associated with any clinical features or overall and relapse-free survival., Conclusions: Our results showed that SET is significantly overexpressed in pediatric acute lymphoblastic leukemia samples, and an increased level of SET might contribute to leukemic process.
- Published
- 2012
- Full Text
- View/download PDF
41. VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study).
- Author
-
Adas G, Percem A, Adas M, Kemik O, Arikan S, Ustek D, Cakiris A, Abaci N, Kemik AS, Kamali G, Karahan S, Akcakaya A, and Karatepe O
- Subjects
- Anastomosis, Surgical, Animals, Disease Models, Animal, Follow-Up Studies, Ischemia etiology, Ischemia pathology, Male, Postoperative Complications, Rats, Rats, Wistar, Treatment Outcome, Colon blood supply, Colon surgery, Fibroblast Growth Factors therapeutic use, Ischemia drug therapy, Vascular Endothelial Growth Factor A therapeutic use, Wound Healing drug effects
- Abstract
Background: Reducing ischemic damage is one of the goals of surgery. The aim of this study was to apply human VEGF-A and FGF-2 DNA-mediated gene therapy in order to identify their effects in the healing of ischemic colon anastomoses and eliminating the negative effects of ischemia., Methods: Forty male Wistar albino rats weighing 250-280 g were divided into five equal groups (n = 8) as follows: group 1: control, ischemic left colonic anastomosis; group; 2: ischemic left colonic anastomosis with control plasmid delivery; group 3: ischemic left colonic anastomosis with VEGF plasmid delivery; group 4: ischemic left colonic anastomosis with FGF plasmid delivery; group 5: ischemic left colonic anastomosis with VEGF and FGF plasmid delivery. All rats were sacrificed on the 4th postoperative day. Anastomosis burst pressures were measured for mechanical examination of anastomosis. Tissue hydroxyprolin, VEGF and FGF levels were determined as biochemical parameters. Necrosis, epithelisation, inflammatory processes, fibroblastic activity, collagen deposition and neovascularisation at the anastomic site were studied., Results: VEGF, FGF and combined therapy significantly accelerated many of the histological parameters of healing, including fibroblast activation, collagen deposition, and angiogenesis, and augmented the levels of hydroxyproline and bursting pressure., Conclusions: This is the first study to use gene therapy with growth factors for the healing of ischemic colonic anastomosis. This therapy can be effectively used in increasing ischemic anastomosis wound healing., (Copyright © 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
42. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis.
- Author
-
Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, and Gül A
- Subjects
- Adolescent, Adult, Aged, Alleles, Female, Gene Frequency, Genetic Association Studies, Genotype, Humans, Male, Middle Aged, Mutation, Missense, Odds Ratio, Pyrin, Turkey, Cytoskeletal Proteins genetics, Spondylitis, Ankylosing genetics
- Abstract
Objective: The pathogenesis of ankylosing spondylitis (AS) has a strong genetic contribution. Familial Mediterranean fever (FMF) is an autosomal recessively inherited autoinflammatory disorder caused by MEFV gene missense variations, and a clinical association between FMF and AS has been reported previously. The aim of this study was to analyze the association of common MEFV variations (M694V, M680I, V726A, and E148Q) with AS in a group of Turkish patients., Methods: The study group comprised 193 patients with AS and 103 matched healthy control subjects. All individuals were genotyped for 4 MEFV variations and HLA-B27 using genomic DNA, and association of the variations with the clinical and laboratory features of the patients was analyzed., Results: The MEFV missense variations were significantly more frequent in patients with AS (22.3%) compared with healthy control subjects (9.7%; odds ratio [OR] 2.67, 95% confidence interval [95% CI] 1.28-5.56). This difference was more prominent for exon 10 variations (M694V, V726A, M680I) (OR 3.75, 95% CI 1.41-9.97), especially for the most-penetrant variation M694V (OR 4.73, 95% CI 1.39-16.12). MEFV variations were more frequent in HLA-B27-negative patients with AS, and the difference was statistically significant in patients carrying exon 10 variants., Conclusion: FMF-related MEFV variations are associated with AS, and these variations may contribute to the pathogenesis of AS, especially in populations in which the prevalence of FMF is high., (Copyright © 2010 by the American College of Rheumatology.)
- Published
- 2010
- Full Text
- View/download PDF
43. The variations of BOP gene in hypertrophic cardiomyopathy.
- Author
-
Abaci N, Güleç C, Bayrak F, Kömürcü Bayrak E, Kahveci G, and Erginel Unaltuna N
- Subjects
- Adolescent, Adult, Aged, Animals, Chickens, Chromosomes, Human, Pair 21, Cross-Sectional Studies, DNA-Binding Proteins genetics, Echocardiography, Transesophageal, Electroencephalography, Female, Humans, Male, Mice, Middle Aged, Muscle Proteins genetics, RNA-Binding Proteins, Reference Values, Transcription Factors genetics, CD8 Antigens genetics, Cardiomyopathy, Hypertrophic genetics, Genetic Variation, Mutation, Proteins genetics
- Abstract
Objective: The observation that Bop null allele mice show underdeveloped right ventricle and excessive development of left ventricle, suggests the possible relationship between human BOP gene and hypertrophic cardiomyopathy (HCMP). In our study, we investigated this possible relationship between BOP gene variations and QT dispersion, a noninvasive arrhythmic risk marker for HCMP., Methods: This cross-sectional study consisted of 50 patients clinically diagnosed with HCMP and 60 healthy subjects. Exonic regions of BOP gene were amplified by polymerase chain reaction and amplified exonic regions were analyzed by Single-Strand Conformation Polymorphisms (SSCP). The samples with different migration patterns were sequenced through an automated sequencing system. Continuous variables were compared by unpaired t-test for independent samples or Mann-Whitney U test. Genotype-disease relationship was tested by Chi-square test., Results: The nucleotide substitutions G275
- Published
- 2010
- Full Text
- View/download PDF
44. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.
- Author
-
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O'Shea J, Wallace GR, Gadina M, Kastner DL, and Gül A
- Subjects
- Alleles, Asia, Behcet Syndrome immunology, Case-Control Studies, Europe, HLA-B Antigens genetics, HLA-B Antigens immunology, Humans, Interleukin-10 immunology, Middle East, Polymorphism, Single Nucleotide, Turkey, Behcet Syndrome genetics, Genes, MHC Class I genetics, Genome-Wide Association Study, Interleukin-10 genetics
- Abstract
Behçet's disease is a genetically complex disease of unknown etiology characterized by recurrent inflammatory attacks affecting the orogenital mucosa, eyes and skin. We performed a genome-wide association study with 311,459 SNPs in 1,215 individuals with Behçet's disease (cases) and 1,278 healthy controls from Turkey. We confirmed the known association of Behçet's disease with HLA-B*51 and identified a second, independent association within the MHC Class I region. We also identified an association at IL10 (rs1518111, P = 1.88 x 10(-8)). Using a meta-analysis with an additional five cohorts from Turkey, the Middle East, Europe and Asia, comprising a total of 2,430 cases and 2,660 controls, we identified associations at IL10 (rs1518111, P = 3.54 x 10(-18), odds ratio = 1.45, 95% CI 1.34-1.58) and the IL23R-IL12RB2 locus (rs924080, P = 6.69 x 10(-9), OR = 1.28, 95% CI 1.18-1.39). The disease-associated IL10 variant (the rs1518111 A allele) was associated with diminished mRNA expression and low protein production.
- Published
- 2010
- Full Text
- View/download PDF
45. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever.
- Author
-
Ustek D, Ekmekçi C, Oku B, Coşan F, Cakiris A, Abaci N, Celik S, Kamali S, Hatemi G, Kasapçopur O, Ozdoğan H, and Gül A
- Subjects
- Alu Elements genetics, Case-Control Studies, Haplotypes, Humans, Promoter Regions, Genetic genetics, Pyrin, 3' Untranslated Regions genetics, Cytoskeletal Proteins genetics, Familial Mediterranean Fever genetics, Genetic Predisposition to Disease genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Objective: Familial Mediterranean fever (FMF), an autosomal recessively inherited autoinflammatory disorder, is caused by missense mutations in the pyrin-encoding MEFV gene. The MEFV mutations can be detected in the majority of FMF patients, but there is an important proportion of patients with the FMF phenotype who carry a single or no coding region mutation. This study aimed to investigate the promoter region and 3'-UTR polymorphisms of the MEFV gene in a group of FMF patients with no coding region mutations, to identify variations with a possible role in the regulation of MEFV expression., Methods: The study group consisted of 289 patients with FMF and 103 ethnically-matched healthy individuals of Turkish origin. All individuals were first genotyped for the five most commonly observed mutations (M694V, M680I, V726A, E148Q and M694I). Then, the coding regions of the MEFV gene in patients carrying none of the 5 mutations were amplified and screened using single-stranded conformation polymorphism and DNA sequencing. After the exclusion of patients with mutations in exons, the promoter and 3'-UTR regions of the MEFV gene were investigated in the remainder. For the haplotype analysis, all study groups were genotyped for two of the 3'-UTR single nucleotide polymorphisms (SNP)., Results: Genotyping for five mutations revealed 186 patients (64.4%) with two mutations, 61 patients (21.1%) with one mutation, and 42 patients (14.5%) with no mutation. The carrier rate for healthy controls was found to be 10%. After screening all 10 exons in the patients with none of the 5 mutations, we identified 36 patients (12.5%) who had no coding region mutations. Analysis of the 3'-UTR region in these patients showed two Alu repeats (AluSx and AluSq), which were located in the 3'-UTR of the reference mRNA sequence. Sequencing of the 3'-UTR of the MEFV gene showed several SNPs that were clustered in 2 haplotypes. When we genotyped all study groups for two of the 3'-UTR SNPs (rs2741918 and rs450021), we observed a significant increase in the frequency of heterozygotes for the 3'-UTR haplotypes in the FMF patients with no coding region polymorphisms compared to the healthy controls (75% versus 48.5%, p=0.006, OR=3.2, 95% CI 1.4-7.4)., Conclusion: This study showed a group of 3'-UTR polymorphisms in the MEFV gene that are clustered in two haplotypes. In addition, a genetic association was observed between 3'-UTR polymorphisms and the FMF patients with no coding region mutations. These findings may suggest a role for 3'-UTR sequences in the regulation of MEFV expression.
- Published
- 2008
46. Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients.
- Author
-
Sen F, Demirturk M, Abaci N, Golcuk E, Oflaz H, Elitok A, Kutluturk F, Issever H, Unaltuna NE, and Ozbey NC
- Subjects
- Adult, Atherosclerosis complications, Case-Control Studies, Cholesterol, LDL blood, Cross-Sectional Studies, Female, Genotype, Growth Hormone deficiency, Humans, Hypopituitarism complications, Insulin-Like Growth Factor I metabolism, Introns genetics, Male, Middle Aged, Atherosclerosis genetics, Hypopituitarism genetics, Nitric Oxide Synthase Type III genetics, Polymorphism, Genetic
- Abstract
Objective: Endothelial nitric oxide synthase (eNOS) intron 4a/b polymorphism is associated with plasma NO concentrations and coronary artery disease/hypertension in various populations. GH deficiency in adulthood predisposes to reduced NO concentrations and premature atherosclerosis. Our aim was to determine whether intron 4a/b polymorphism of eNOS gene influences endothelial function and early atherosclerotic changes in GH-deficient hypopituitary patients., Design: Thirty-three hypopituitary GH-deficient patients on conventional replacement therapy other than GH and 43 age-, sex-, and body mass index (BMI)-matched controls were studied in this cross-sectional case-control study., Methods: Early atherosclerotic changes were determined by flow-mediated dilation (FMD) of brachial artery and carotid artery intima-media thickness (IMT). eNOS4a/b polymorphism was detected by PCR., Results: Hypopituitary patients had significantly higher total/low-density lipoprotein cholesterol and fat mass and lower IGF-I concentrations compared with controls. IMT was significantly higher in patients (0.777+/-0.23 vs 0.639+/-0.17 mm, P<0.01). No significant difference was observed with respect to FMD measurements. eNOS4a/b genotype frequencies were similar between patients and controls. Patients carrying 'a' allele (a/a and a/b) had significantly higher IMT compared with controls carrying 'a' allele and bb genotype (P<0.05). However, logistic regression analysis revealed that presence of hypopituitarism, age> or =45 years, and BMI> or =27.9 kg/m(2) were significant independent predictors of IMT> or =0.65 mm., Conclusion: No compelling data are evident to suggest that eNOS4a/b polymorphism modifies the atherosclerotic process in GH-deficient situations. A large case-control study is needed to confirm our findings.
- Published
- 2008
- Full Text
- View/download PDF
47. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
- Author
-
Okumus G, Kiyan E, Arseven O, Tabak L, Diz-Kucukkaya R, Unlucerci Y, Abaci N, Unaltuna NE, and Issever H
- Subjects
- Adolescent, Adult, Aged, Factor V genetics, Female, Homocysteine blood, Humans, Logistic Models, Male, Middle Aged, Mutation, Protein C metabolism, Prothrombin genetics, Risk Factors, Thrombophilia genetics, Thrombophilia etiology, Venous Thromboembolism etiology
- Abstract
The aim of this study was to investigate the hereditary thrombophilic risk factors in patients with venous thromboembolism (VTE) and whether these risk factors play a different role in patients with isolated pulmonary embolism (PE) as compared with patients with deep vein thrombosis (DVT) and patients with PE + DVT. The protein C (PC), protein S, antithrombin activities, homocysteine levels, and factor V Leiden (FVL) G1691A and prothrombin G20210A mutations were evaluated in 191 patients with VTE and 191 controls. The prevalence of FVL and PC deficiency were higher in patients (P = .003 and P = .02, respectively). There was no significant difference for the other risk factors. The combination of thrombophilic risk factors was significantly higher in patients with DVT + PE as compared with patients with isolated PE or DVT (P = .04). In conclusion, the most important hereditary risk factors for VTE in this study were the FVL mutation and PC deficiency.
- Published
- 2008
- Full Text
- View/download PDF
48. Prothrombotic gene mutations and Crohn's disease; is there any association?
- Author
-
Over-Hamzaoglu H, Abaci N, Türe F, Alkim C, Tezel A, Avsar E, and Tözün N
- Subjects
- Adult, Aged, Aged, 80 and over, Crohn Disease blood, Crohn Disease complications, Female, Gene Frequency, Humans, Male, Middle Aged, Thromboembolism etiology, Thromboembolism genetics, Crohn Disease genetics, Factor V genetics, Point Mutation, Prothrombin genetics
- Abstract
Background/aims: Patients with inflammatory bowel disease have an increased tendency for thromboembolism. In this study we aimed to determine the frequency of FV gene and Prothrombin G20210A gene mutations in a group of patients with Crohn's Disease (CD) and estimate its correlation with disease activity and clinical subtype., Methodology: Forty-four CD patients and 43 healthy controls were included in the study. Twenty-three of the patients had inflammatory CD, while 11 had fibrostenotic and 10 had fistulizing CD. Only one patient had a history of deep vein thrombosis. Polymorphism Light Cycler FV Leiden mutation detection kit and Light Cycler prothrombin (G20210A) mutation detection kit were used for the detection of mutations in DNA samples., Results: Forty of the CD patients had normal factor V genotype, three (6.8%) patients showed a heterozygous, and one (2.3%) patient homozygous pattern. Two (4.7%) of the 43 controls showed heterozygous factor V mutation and 41 had normal FV genotype. Two (4.6%) CD patients had heterozygous prothrombin G20210A mutation, and there was only one (2.3%) homozygous mutation in the control group. There was no significant difference between controls and CD patients neither for factor V mutation (p > 0.05) nor for prothrombin G20210A mutations (p > 0.05). No correlation was found between disease activity and both gene mutations (p > 0.05), as well as between disease subtype and gene mutations (p > 0.05)., Conclusions: The prevalence of prothrombin G20210A gene and factor V Leiden gene mutations were found to be statistically insignificant among CD patients and control group.
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.